Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy

scientific article

Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSPROCEED.2005.02.112
P698PubMed publication ID15919494

P2093author name stringFerluga D
Kandus A
Lindic J
Ponikvar R
Vizjak A
Bren A
Buturovic J
Grego K
Knap B
Pajek J
P2860cites workCyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluationQ33502838
Renal vascular and thrombotic effects of cyclosporineQ38617129
Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?Q74816884
Cyclosporine-associated thrombotic microangiopathy in renal allograftsQ77829502
P433issue4
P407language of work or nameEnglishQ1860
P921main subjecthemolytic-uremic syndromeQ162266
P304page(s)1889-1891
P577publication date2005-05-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleFollow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy
P478volume37

Reverse relations

cites work (P2860)
Q33395560A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation
Q39350215Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants.
Q33411363Blood disorders after kidney transplantation
Q38241710Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients
Q36649380Critical care perspective on immunotherapy in lung transplantation
Q33403602De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival
Q33439133De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab
Q34560483Drug-associated renal dysfunction and injury
Q39062280Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.
Q57151742Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
Q38578386The safety of calcineurin inhibitors for kidney-transplant patients
Q33372586Thrombotic microangiopathy after kidney transplantation
Q33378578Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimus
Q37589777Thrombotic microangiopathy in renal allografts
Q33378757Thrombotic microangiopathy in the early post-renal transplant period

Search more.